ヘルスケア事業においては、「ITはなびらたけ」サプリメントの機能性表示食品化に向けて対応を進めている。2024年9月期での取得には至らなかったが、実現できた場合には、業績への大きな貢献が期待される。さらに、中国における化粧品販売に高い実績があるアクシージア＜4936＞と2023年3月に戦略的業務提携契約を締結した。「ITはなびらたけ」を使用したサプリメント分野に関しては、産学官の研究開発に始まり、女性60名以上を対象としたヒト臨床試験を実施、更年期女性の不快症状を緩和する効果に関して論文を発表するなど、研究データ等が整っている。しかし、化粧品分野に関しては研究開発等が十分とは言えない状況にあるため、アクシージアとの業務提携により化粧品分野での研究開発を推進することで、将来的な同領域での展開を見据えている。■Strengths of InterTrade Co., Ltd. <3747>
It can be said that the greatest strength lies in the fact that many small local securities companies, which are considered to have difficulty developing their own superior systems, rely on the company's system for implementation. The fact that the company's representative director, Kazuya Nishimoto, comes from a securities system background also serves as a basis for providing advanced systems and enhances reliability, according to our company.
In the core market of securities system, financial services utilizing new technologies are expanding globally. In such a context, the company plans to explore new growth areas through the "Spider Digital Transfer" solution, which compacts and deepens system functionalities according to customer operations by picking up or merging necessary process and application functions from multiple package systems for financial products trading.
In the Health Care business, efforts are being made towards the functional labeling of the "IT Hanabiratake" supplement. Although acquisition was not achieved by the September 2024 period, a significant contribution to performance is expected if realized. Furthermore, a strategic partnership agreement was signed in March 2023 with Axisia <4936>, which has a strong track record in cosmetics sales in China. Regarding the supplement field using "IT Hanabiratake", research and development involving academia and government began, and a human clinical trial targeting over 60 women was conducted to publish papers on its effects in alleviating discomfort symptoms in menopausal women, thereby confirming the availability of research data. However, since research and development in the cosmetic field are currently not sufficient, future expansion into this area is anticipated by promoting cooperative research and development with Axisia.
(Writer: FISCO analyst Tomoichi Murase)
